Helix BioPharma's market cap is currently C$51.96M. The company's EPS TTM is C$-0.201; its P/E ratio is ―; Helix BioPharma is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -14.00K	C$ -13.00K	C$ -12.00K	C$ -173.00K	C$ -212.00K
Operating Income	C$ -9.37M	C$ -6.28M	C$ -6.54M	C$ -9.61M	C$ -8.59M
EBITDA	C$ -9.38M	C$ -6.31M	C$ -6.03M	C$ -9.46M	C$ -8.44M
Net Income	C$ -9.26M	C$ -6.29M	C$ -6.08M	C$ -7.91M	C$ -9.01M
Balance Sheet
Cash & Short-Term Investments	C$ 1.08M	C$ 808.00K	C$ 3.25M	C$ 3.56M	C$ 4.24M
Total Assets	C$ 1.49M	C$ 1.03M	C$ 3.73M	C$ 4.07M	C$ 4.91M
Total Debt	C$ 0.00	C$ 0.00	C$ 2.47M	C$ 3.61M	C$ 159.00K
Net Debt	C$ -1.08M	C$ -808.00K	C$ -784.00K	C$ 47.00K	C$ -4.08M
Total Liabilities	C$ 1.58M	C$ 1.87M	C$ 3.41M	C$ 5.46M	C$ 1.93M
Stockholders' Equity	C$ -90.00K	C$ -844.00K	C$ 319.00K	C$ -1.39M	C$ 2.39M
Cash Flow
Free Cash Flow	C$ -5.23M	C$ -5.54M	C$ -6.51M	C$ -9.30M	C$ -10.84M
Operating Cash Flow	C$ -5.22M	C$ -5.53M	C$ -6.51M	C$ -9.30M	C$ -10.83M
Investing Cash Flow	C$ -14.00K	C$ -5.00K	C$ 0.00	C$ 2.02M	C$ 1.70M
Financing Cash Flow	C$ 5.51M	C$ 3.09M	C$ 6.21M	C$ 6.56M	C$ 13.10M

Currency in CAD

Helix BioPharma Earnings and Revenue History

Income Statement >

Helix BioPharma Debt to Assets

Balance Sheet >

Helix BioPharma Cash Flow

Cash Flow >

Helix BioPharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing